# Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer

> **NCT01060514** · PHASE1 · TERMINATED · sponsor: **Northwestern University** · enrollment: 8 (actual)

## Conditions studied

- Metastatic Non Small Cell Lung Cancer
- Metastatic Breast Cancer

## Interventions

- **DRUG:** Pazopanib
- **DRUG:** Vinorelbine

## Key facts

- **NCT ID:** NCT01060514
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-02
- **Primary completion:** 2012-02
- **Final completion:** 2013-09
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Lack of timely accrual.
- **Last updated:** 2013-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060514, "Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01060514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*